Answers are grounded in this paper and cite their sources.
INTRODUCTION: Venous thromboembolic disease (VTED), including deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a serious postoperative complication following total hip arthroplasty (THA). While revision THA is traditionally considered higher risk than primary THA, the thromboembolic risks of conversion THA are still not well defined. This study compared 30-day DVT rates across primary, conversion, and revision THA. METHODS: A retrospective cross-sectional analysis was performed using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. Adult patients undergoing primary, conversion, or revision THA were identified using Current Procedural Terminology (CPT) codes. A total of 475,002 patients met inclusion criteria (primary THA: 428,245 [90.2%], conversion THA: 10,637 [2.2%], revision THA: 36,120 [7.6%]) with a mean age of 65.6 years (range, 18 to 89); 55.0% women. The primary outcome was 30-day postoperative DVT. Multivariable logistic regressions evaluated associations between procedure type and DVT, adjusting for age, sex, BMI, American Society of Anesthesiologists (ASA) class, smoking status, chronic steroid use, and operating time. Independent predictors of higher DVT risk included older age, longer operating time, and chronic steroid use. Sex, BMI, ASA class, and smoking status were not independently associated with DVT. CONCLUSIONS: Conversion THA is associated with higher 30-day DVT risk compared with both primary and revision THA on multivariable analyses. Recognition of conversion THA as a distinct procedural category associated with higher relative thromboembolic risk may improve perioperative risk stratification and guide more individualised thromboprophylaxis strategies.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: